A systematic review and meta-analysis of diagnostic accuracy of serum 1,3-β-d-glucan for invasive fungal infection: Focus on cutoff levels

Journal of Microbiology, Immunology and Infection

Volumn 48, Issue 4, 2015, Pages 351-361

  He, Song ^a   Hang, Ju Ping ^a   Zhang, Ling ^a   Wang, Fang ^a   Zhang, De Chun ^b   Gong, Fang Hong ^c  

^a Maanshan People Hospital   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

^c Sichuan Center for Disease Control and Prevention   (China)

Author keywords

1,3 d Glucan (BDG); Diagnosis; Invasive fungal infection (IFI); Meta analysis; Systematic review

Indexed keywords

1,3 BETA DEXTRO GLUCAN; GLUCAN; UNCLASSIFIED DRUG; BETA GLUCAN; BETA-1,3-D-GLUCAN;

ASPERGILLUS; CANDIDA; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FUNGUS TEST KIT; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; NONHUMAN; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; SYSTEMIC MYCOSIS; BLOOD; FUNGEMIA;

BETA-GLUCANS; FUNGEMIA; HUMANS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84938290649     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2014.06.009     Document Type: Review

References (41)

1. De Vlieger G., Lagrou K., Maertens J., Verbeken E., Meersseman W., Van Wijngaerden E. Beta-d-glucan detection as a diagnostic test for invasive aspergillosis in immunocompromised critically ill patients with symptoms of respiratory infection: an autopsy-based study. J Clin Microbiol 2011, 49:3783-3787.
2. Lin H.C., Lin H.Y., Su B.H., Ho M.W., Ho C.M., Lee C.Y., et al. Reporting an outbreak of Candida pelliculosa fungemia in a neonatal intensive care unit. J Microbiol Immunol Infect 2013, 46:456-462.
3. Pagano L., Caira M., Candoni A., Offidani M., Fianchi L., Martino B., et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 2006, 91:1068-1075.
4. Kedzierska A., Kochan P., Pietrzyk A., Kedzierska J. Current status of fungal cell wall components in the immunodiagnostics of invasive fungal infections in humans: galactomannan, mannan and (1-->3)-beta-d-glucan antigens. Eur J Clin Microbiol Infect Dis 2007, 26:755-766.
5. Theel E.S., Doern C.D. β-d-Glucan testing is important for diagnosis of invasive fungal infections. J Clin Microbiol 2013, 51:3478-3483.
6. De Pauw B., Walsh T.J., Donnelly J.P., Stevens D.A., Edwards J.E., Calandra T., et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008, 46:1813-1821.
7. Onishi A., Sugiyama D., Kogata Y., Saegusa J., Sugimoto T., Kawano S., et al. Diagnostic accuracy of serum 1,3-β-d-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis. J Clin Microbiol 2012, 50:7-15.
8. Lamoth F., Cruciani M., Mengoli C., Castagnola E., Lortholary O., Richardson M., et al. β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3). Clin Infect Dis 2012, 54:633-643.
9. Ascioglu S., Rex J.H., de Pauw B., Bennett J.E., Bille J., Crokaert F., et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002, 34:7-14.
10. Leeflang M.M., Deeks J.J., Gatsonis C., Bossuyt P.M. Cochrane Diagnostic Test Accuracy Working Group. Systematic reviews of diagnostic test accuracy. Ann Intern Med 2008, 149:889-897.
11. Whiting P., Rutjes A.W., Reitsma J.B., Bossuyt P.M., Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003, 3:25.
12. Karageorgopoulos D.E., Vouloumanou E.K., Ntziora F., Michalopoulos A., Rafailidis P.I., Falagas M.E. β-d-Glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis 2011, 52:750-770.
13. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
14. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558.
15. Metan G., Koç A.N., Atalay A., Kaynar L.G., Ozturk A., Alp E., et al. What should be the optimal cut-off of serum 1,3-β-d-glucan for the detection of invasive pulmonary aspergillosis in patients with haematological malignancies?. Scand J Infect Dis 2012, 44:330-336.
16. Posteraro B., De Pascale G., Tumbarello M., Torelli R., Pennisi M.A., Bello G., et al. Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-d-glucan assay, Candida score, and colonization index. Crit Care 2011, 15:R249.
17. Acosta J., Catalan M., del Palacio-Peréz-Medel A., Lora D., Montejo J.C., Cuetara M.S., et al. A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→3)-β-d-glucan chromogenic assay in serum samples. Clin Microbiol Infect 2011, 17:1053-1060.
18. Racil Z., Kocmanova I., Lengerova M., Weinbergerova B., Buresova L., Toskova M., et al. Difficulties in using 1,3-{beta}-d-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies-high frequency of false-positive results and their analysis. J Med Microbiol 2010, 59:1016-1022.
19. Alexander B.D., Smith P.B., Davis R.D., Perfect J.R., Reller L.B. The (1,3){beta}-d-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation. J Clin Microbiol 2010, 48:4083-4088.
20. Hirata Y., Yokote T., Kobayashi K., Nakayama S., Oka S., Miyoshi T., et al. Antifungal prophylaxis with micafungin in neutropenic patients with hematological malignancies. Leuk Lymphoma 2010, 51:853-859.
21. León C., Ruiz-Santana S., Saavedra P., Galván B., Blanco A., Castro C., et al. Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med 2009, 37:1624-1633.
22. Lunel F.M., Mennink-Kersten M.A., Ruegebrink D., van der Lee H.A., Donnelly J.P., Blijlevens N.M., et al. Value of Candida serum markers in patients with invasive candidiasis after myeloablative chemotherapy. Diagn Microbiol Infect Dis 2009, 64:408-415.
23. Hachem R.Y., Kontoyiannis D.P., Chemaly R.F., Jiang Y., Reitzel R., Raad I. Utility of galactomannan enzyme immunoassay and (1,3) beta-d-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients. J Clin Microbiol 2009, 47:129-133.
24. Koo S., Bryar J.M., Page J.H., Baden L.R., Marty F.M. Diagnostic performance of the (1-->3)-beta-d-glucan assay for invasive fungal disease. Clin Infect Dis 2009, 49:1650-1659.
25. Presterl E., Parschalk B., Bauer E., Lassnigg A., Hajdu S., Graninger W. Invasive fungal infections and (1,3)-beta-d-glucan serum concentrations in long-term intensive care patients. Int J Infect Dis 2009, 13:707-712.
26. Obayashi T., Negishi K., Suzuki T., Funata N. Reappraisal of the serum (1-->3)-beta-d-glucan assay for the diagnosis of invasive fungal infections-a study based on autopsy cases from 6 years. Clin Infect Dis 2008, 46:1864-1870.
27. Senn L., Robinson J.O., Schmidt S., Knaup M., Asahi N., Satomura S., et al. 1,3-Beta-d-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin Infect Dis 2008, 46:878-885.
28. Persat F., Ranque S., Derouin F., Michel-Nguyen A., Picot S., Sulahian A. Contribution of the (1-->3)-beta-d-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 2008, 46:1009-1013.
29. Ellis M., Al-Ramadi B., Finkelman M., Hedstrom U., Kristensen J., Ali-Zadeh H., et al. Assessment of the clinical utility of serial beta-d-glucan concentrations in patients with persistent neutropenic fever. J Med Microbiol 2008, 57:287-295.
30. Alam F.F., Mustafa A.S., Khan Z.U. Comparative evaluation of (1, 3)-beta-d-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia. BMC Infect Dis 2007, 7:103.
31. Akamatsu N., Sugawara Y., Kaneko J., Tamura S., Makuuchi M. Preemptive treatment of fungal infection based on plasma (1-->3)beta-d-glucan levels after liver transplantation. Infection 2007, 35:346-351.
32. Fujita S., Takamura T., Nagahara M., Hashimoto T. Evaluation of a newly developed down-flow immunoassay for detection of serum mannan antigens in patients with candidaemia. J Med Microbiol 2006, 55:537-543.
33. Ostrosky-Zeichner L., Alexander B.D., Kett D.H., Vazquez J., Pappas P.G., Saeki F., et al. Multicenter clinical evaluation of the (1-->3) beta-d-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005, 41:654-659.
34. Pazos C., Pontón J., Del Palacio A. Contribution of (1->3)-beta-d-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol 2005, 43:299-305.
35. Pickering J.W., Sant H.W., Bowles C.A., Roberts W.L., Woods G.L. Evaluation of a (1->3)-beta-d-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 2005, 43:5957-5962.
36. Kawazu M., Kanda Y., Nannya Y., Aoki K., Kurokawa M., Chiba S., et al. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1-->3)-beta-d-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders. J Clin Microbiol 2004, 42:2733-2741.
37. Kondori N., Edebo L., Mattsby-Baltzer I. Circulating beta (1-3) glucan and immunoglobulin G subclass antibodies to Candida albicans cell wall antigens in patients with systemic candidiasis. Clin Diagn Lab Immunol 2004, 11:344-350.
38. Odabasi Z., Mattiuzzi G., Estey E., Kantarjian H., Saeki F., Ridge R.J., et al. Beta-d-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004, 39:199-205.
39. Mori T., Ikemoto H., Matsumura M., Yoshida M., Inada K., Endo S., et al. Evaluation of plasma (1-->3)-beta-d-glucan measurement by the kinetic turbidimetric Limulus test, for the clinical diagnosis of mycotic infections. Eur J Clin Chem Clin Biochem 1997, 35:553-560.
40. Miyazaki T., Kohno S., Mitsutake K., Maesaki S., Tanaka K., Ishikawa N., et al. Plasma (1-->3)-beta-d-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis. J Clin Microbiol 1995, 33:3115-3118.
41. Obayashi T., Yoshida M., Mori T., Goto H., Yasuoka A., Iwasaki H., et al. Plasma (1-->3)-beta-d-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995, 345:17-20.